CB
Cadence Bank’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,395
| Closed | -$251K | – | 325 |
|
|
2024
Q4 | $251K | Hold |
3,395
| – | – | 0.02% | 297 |
|
|
2024
Q3 | $224K | Sell |
3,395
-29
| -0.8% | -$1.91K | 0.02% | 314 |
|
|
2024
Q2 | $316K | Buy |
3,424
+244
| +8% | +$22.5K | 0.02% | 236 |
|
|
2024
Q1 | $304K | Hold |
3,180
| – | – | 0.02% | 275 |
|
|
2023
Q4 | $242K | Sell |
3,180
-119
| -4% | -$9.07K | 0.02% | 300 |
|
|
2023
Q3 | $229K | Buy |
3,299
+2
| +0.1% | +$139 | 0.02% | 304 |
|
|
2023
Q2 | $311K | Buy |
3,297
+92
| +3% | +$8.68K | 0.03% | 275 |
|
|
2023
Q1 | $265K | Hold |
3,205
| – | – | 0.02% | 290 |
|
|
2022
Q4 | $239K | Hold |
3,205
| – | – | 0.02% | 304 |
|
|
2022
Q3 | $265K | Hold |
3,205
| – | – | 0.03% | 280 |
|
|
2022
Q2 | $305K | Hold |
3,205
| – | – | 0.04% | 159 |
|
|
2022
Q1 | $377K | Buy |
3,205
+25
| +0.8% | +$2.94K | 0.05% | 152 |
|
|
2021
Q4 | $412K | Hold |
3,180
| – | – | 0.05% | 154 |
|
|
2021
Q3 | $360K | Hold |
3,180
| – | – | 0.05% | 157 |
|
|
2021
Q2 | $329K | Hold |
3,180
| – | – | 0.05% | 162 |
|
|
2021
Q1 | $266K | Buy |
3,180
+300
| +10% | +$25.1K | 0.04% | 173 |
|
|
2020
Q4 | $263K | Hold |
2,880
| – | – | 0.04% | 192 |
|
|
2020
Q3 | $230K | Buy |
+2,880
| New | +$230K | 0.05% | 167 |
|
|
2020
Q1 | – | Sell |
-960
| Closed | -$224K | – | 189 |
|
|
2019
Q4 | $224K | Hold |
960
| – | – | 0.04% | 180 |
|
|
2019
Q3 | $211K | Buy |
+960
| New | +$211K | 0.02% | 211 |
|